Literature DB >> 2092360

Isolation, purification and partial analysis of the lipopolysaccharide antigenic determinant recognized by a monoclonal antibody to Legionella pneumophila serogroup 1.

F Petitjean1, E Dournon, A D Strosberg, J Hoebeke.   

Abstract

Monoclonal antibody II-6-18 recognizes a serogroup-1-specific Legionella pneumophila antigenic determinant which has been shown to be virulence-associated. We previously reported the physicochemical characterization by means of a quantitative fluorometric assay of monoclonal antibody II-6-18 binding to L. pneumophila, and its implications concerning the nature of the antigen. We describe here the isolation and the purification of the antigen by chemical and immunological methods, followed by its partial chemical analysis. The results demonstrate that the epitope--an immunodominant carbohydrate which includes a fucosamine-like residue--is part of the cell wall lipopolysaccharide (LPS). It is localized in the polysaccharide moiety of the LPS which contains KDO, rhamnose, mannose, glucosamine and an unidentified aminodideoxyhexose X1, but no heptose. The aminodideoxyhexose X1 could be fucosamine and is probably the immunodominant residue in the epitope, localized, at least partially, at the end of the polysaccharide chain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2092360     DOI: 10.1016/0923-2508(90)90082-2

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  2 in total

1.  Use of multiple molecular subtyping techniques to investigate a Legionnaires' disease outbreak due to identical strains at two tourist lodges.

Authors:  M Mamolen; R F Breiman; J M Barbaree; R A Gunn; K M Stone; J S Spika; D T Dennis; S H Mao; R L Vogt
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

2.  Molecular characterization of a virulence-associated epitope on the lipopolysaccharide of Legionella pneumophila serogroup 1.

Authors:  J H Helbig; P C Lück; Y A Knirel; W Witzleb; U Zähringer
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.